IL-13Rα2 is a high affinity membrane receptor that is overexpressed in glioblastoma, and is associated with poor outcome, mesenchymal gene profile, immunity, and the tumor microenvironment, which make it an important therapeutic target (145, 146). This evidence concerns the gene IL13RA2 and neoplasm.